KMTS - Wutah pendapatan taun lumaku Kestra Medical Corp

The disciplined management of Kestra Medical Technologies (KMTS) is effectively overcoming FDA barriers, which, combined with optimized courier delivery of devices to patients, is positively impacting revenue dynamics. This 12-month YoY sales chart confirms this trend, where the latest parameter stands at 61.20. The large-scale commercialization of wearable defibrillators in the US will drive further expansive growth for the company.
kestramedical.com (KMTS) - rincian metrik lan laporan keuangan

This indicator measures revenue dynamics over a rolling twelve-month period, reflecting the business scaling speed and operational management efficiency in real time. For Kestra Medical Technologies (KMTS), this parameter confirms expansion within the growing cardiac monitoring segment and the growth of its clinic client base, making the year-over-year sales growth percentage (over 4 quarters) a key criterion for assessing investment attractiveness.